Market Size –
The diagnostic contract manufacturing market size has grown rapidly in recent years. It will grow from $27.44 billion in 2023 to $31.29 billion in 2024 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to increasing demand for outsourcing, cost efficiency achieved through outsourcing manufacturing, increasing regulatory requirements for quality and compliance in the diagnostic industry, shortened product lifecycles in the diagnostic market necessitated flexible manufacturing solutions, and globalization of diagnostic companies’ operations and supply chains increased.
The diagnostic contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $53.74 billion in 2028 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to increasing demand for personalized diagnostic tests and companion diagnostics, expansion of point-of-care testing and decentralized diagnostic platforms, tightening regulatory requirements for diagnostic products, increase in outsourcing of specialty testing, such as molecular diagnostics and immunoassays, and shift towards flexible manufacturing. Major trends in the forecast period include adoption of automation and robotics in diagnostic manufacturing processes, utilization of 3D printing technologies for rapid prototyping and customization of diagnostic devices, integration of artificial intelligence (AI) and data analytics into diagnostic manufacturing processes, and implementation of digital twin technology to simulate and optimize manufacturing processes in the virtual environment before physical implementation.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/diagnostic-contract-manufacturing-global-market-report
Scope Of Diagnostic Contract Manufacturing Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Diagnostic Contract Manufacturing Market Overview
Market Drivers –
An increasing focus on preventive healthcare is expected to propel the growth of the diagnostic contract manufacturing market going forward. Preventive healthcare refers to measures taken to prevent the occurrence or development of disease, illness, or injury. The focus on preventive healthcare is due to rising healthcare costs, shifts in healthcare priorities, a rise in chronic diseases, and population aging. Diagnostic contract manufacturing contributes to increasing the focus on preventive healthcare by providing essential diagnostic tools and tests, offering customized solutions, ensuring quality and regulatory compliance, supporting scalability, and enabling cost-effective solutions for disease prevention and early intervention. For instance, in March 2024, according to a report published by Eurostat, a Luxembourg-based government statistical agency, in 2021, expenditure on preventive healthcare in the EU surged by 88.2% compared to the previous year, reaching 0.65% of GDP. Further, immunization programs witnessed a notable rise in their share of total preventive care spending, increasing from 13.7% in 2020 to 29.1% in 2021. Therefore, an increasing focus on preventive healthcare drives the diagnostic contract manufacturing market.
Market Trends –
Major companies operating in the diagnostic contract manufacturing market are adopting a strategic partnership approach to support the production of diagnostic equipment and gain a competitive advantage. A strategic partnership typically refers to a collaborative relationship between two or more organizations combining their resources, expertise, and efforts to achieve common goals or objectives. For instance, in July 2022, Highfield Diagnostics Ltd., a UK-based diagnostics company, collaborated with SCIENION GmbH, a Germany-based bio convergence company offering diagnostic contract manufacturing services, for the development and deployment of equipment for mass manufacturing lateral flow tests (LFTs) incorporating HDx’s flowDx technology. The collaboration aims to utilize SCIENION’s manufacturing capabilities to finalize equipment designs and manufacturing processes for cost-effective and high-throughput production of flowDx-enabled LFTs. flowDx technology, developed over seven years of academic research, enables precise control of fluidic flows in LFTs, allowing for parallel multiplexing, enhanced accuracy, and semi-quantitative results.
The diagnostic contract manufacturing market covered in this report is segmented –
1) By Service: Device Development And Manufacturing Services, Quality Management Services, Packaging And Assembly Services, Other Services
2) By Application: In Vitro Diagnostic Devices, Diagnostic Imaging Devices, Other Applications
3) By End User: Medical Device Companies, Pharmaceutical And Biopharmaceutical Companies, Other End Users
Get an inside scoop of the diagnostic contract manufacturing market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16032&type=smp
Regional Insights –
North America was the largest region in the diagnostic contract manufacturing market in 2023. The regions covered in the diagnostic contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the diagnostic contract manufacturing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Jabil Inc., Flex Ltd., Becton Dickinson and Company (BD), TE Connectivity Ltd., Sekisui Diagnostics LLC, Sanmina Corporation, Celestica Inc., Nipro Medical Corporation, Philips-Medisize Corporation, Plexus Corp, West Pharmaceutical Services Inc., Benchmark Electronics Inc., Bio-Rad Laboratories, QIAGEN N.V., Kimball Electronics Inc., Integer Holdings Corporation, Bio-Techne Corporation, Nolato AB, Nova Biomedical Corporation, Meridian Bioscience Inc., Fujirebio Inc., Biokit S.A., Invetech Pty. Ltd., KMC Systems, Savyon Diagnostics Ltd., Prestige Diagnostics U.K. Ltd., Cenogenic Corporation, Avioq Inc.
Table of Contents
1. Executive Summary
2. Diagnostic Contract Manufacturing Market Report Structure
3. Diagnostic Contract Manufacturing Market Trends And Strategies
4. Diagnostic Contract Manufacturing Market – Macro Economic Scenario
5. Diagnostic Contract Manufacturing Market Size And Growth
…..
27. Diagnostic Contract Manufacturing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
